{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:14:53Z","timestamp":1762521293779},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.riam.2009.01.001","type":"journal-article","created":{"date-parts":[[2009,7,27]],"date-time":"2009-07-27T08:14:02Z","timestamp":1248682442000},"page":"213-217","source":"Crossref","is-referenced-by-count":5,"title":["Coinfecci\u00f3n oportunista durante el tratamiento con infliximab (antifactor de necrosis tumoral alfa) en un paciente con enfermedad de Crohn"],"prefix":"10.1016","volume":"26","author":[{"given":"Miguel","family":"Salavert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Bastida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pem\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Nos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2009.01.001_bib1","first-page":"7","article-title":"Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: A case study and review of the literature","volume":"7","author":"Alderson","year":"2005","journal-title":"Med Gen Med"},{"key":"10.1016\/j.riam.2009.01.001_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1157\/13062892","article-title":"Candidiasis sist\u00e9mica y terapia con infliximab","volume":"27","author":"Belda","year":"2004","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.riam.2009.01.001_bib3","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/art.20454","article-title":"Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists","volume":"50","author":"Bergstrom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.riam.2009.01.001_bib4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/IAI.69.3.1554-1560.2001","article-title":"Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus","volume":"69","author":"Brieland","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.riam.2009.01.001_bib5","first-page":"527","article-title":"Pulmonary cavitation with Nocardia and Aspergillus in a renal transplant patient","volume":"82","author":"Carter","year":"1990","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.riam.2009.01.001_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007611-198402000-00042","article-title":"Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood","volume":"77","author":"Casale","year":"1984","journal-title":"South Med J"},{"key":"10.1016\/j.riam.2009.01.001_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.riam.2009.01.001_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.md.0000180044.19285.9a","article-title":"Infections associated with tumor necrosis factor-alpha antagonists","volume":"84","author":"Crum","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.riam.2009.01.001_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/502250","article-title":"Invasive pulmonary aspergillosis soon after therapy with infliximab, a tumor necrosis factor-alpha-neutralizing antibody: A possible healthcare-associated case?","volume":"24","author":"De Rosa","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.riam.2009.01.001_bib10","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s10620-006-9455-z","article-title":"Mucormycosis presenting as recurrent gastric perforation in a patient with Crohn's disease on glucocorticoid, 6-mercaptopurine, and infliximab therapy","volume":"52","author":"Devlin","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.riam.2009.01.001_bib11","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.riam.2009.01.001_bib12","first-page":"2432","article-title":"Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab","volume":"32","author":"Fabre","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.riam.2009.01.001_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-7753(00)71294-2","article-title":"Lung infection caused by Aspergillus fumigatus and Nocardia asteroides as complication of glucocorticoid treatment","volume":"114","author":"Fern\u00e1ndez Pel\u00e1ez","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.riam.2009.01.001_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1157\/13080266","article-title":"Infectious complications associated with the use of tumor necrosis factor antagonist drugs: A review","volume":"23","author":"Garc\u00eda-Lechuz Moya","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.riam.2009.01.001_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/377235","article-title":"Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists","volume":"37","author":"Gottlieb","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib16","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1378\/chest.124.6.2395","article-title":"Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy","volume":"124","author":"Hage","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.riam.2009.01.001_bib17","doi-asserted-by":"crossref","unstructured":"Hamadani M, Benson Jr DM, Blum W, Garzon R, Devine SM. Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease. Transpl Infect Dis 2007 Jul 25; [Epub ahead of print].","DOI":"10.1111\/j.1399-3062.2007.00268.x"},{"key":"10.1016\/j.riam.2009.01.001_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.semarthrit.2005.01.003","article-title":"Differenciating the efficacy of the tumor necrosis factor inhibitors","volume":"34","author":"Haraoui","year":"2005","journal-title":"Semin Artritis Rheum"},{"key":"10.1016\/j.riam.2009.01.001_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF01967584","article-title":"Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient","volume":"12","author":"Holt","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3201\/eid1306.070154","article-title":"Invasive Cryptococcosis and adalimumab treatment","volume":"13","author":"Horcajada","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2009.01.001_bib22","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/rheumatology\/keh567","article-title":"TNF-blocking agents and tuberculosis: New drugs illuminate an old topic","volume":"44","author":"Keane","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.riam.2009.01.001_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0889-857X(07)70003-0","article-title":"Biologic agents in rheumatology: Safety considerations","volume":"32","author":"Lee","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.riam.2009.01.001_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.riam.2009.01.001_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1157\/13083915","article-title":"Recomendaciones sobre tuberculosis y tratamiento de la enfermedad inflamatoria intestinal con infliximab. Actualizaci\u00f3n, 2006","volume":"29","author":"L\u00f3pez-San","year":"2006","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.riam.2009.01.001_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2310\/7750.2007.00009","article-title":"Invasive Trichophyton rubrum infection occurring with infliximab and long-term prednisone treatment","volume":"11","author":"Lowther","year":"2007","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.riam.2009.01.001_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rdc.2004.01.009","article-title":"Infliximab treatment of rheumatoid arthritis","volume":"30","author":"Maini","year":"2004","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.riam.2009.01.001_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0008-8749(03)00116-3","article-title":"Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses","volume":"222","author":"Mariano Andrade","year":"2003","journal-title":"Cell Immunol"},{"key":"10.1016\/j.riam.2009.01.001_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1196\/annals.1406.027","article-title":"Coccidioidomycosis in rheumatology patients: Incidence and potential risk factors","volume":"1111","author":"Mertz","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.riam.2009.01.001_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/421494","article-title":"Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor","volume":"39","author":"Mohan","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib31","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002281-200305000-00002","article-title":"Infectious complications of biologic treatments of rheumatoid arthritis","volume":"15","author":"Mohan","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.riam.2009.01.001_bib32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF01967585","article-title":"Pneumonia caused by Nocardia nova and Aspergillus fumigatus after cardiac transplantation","volume":"12","author":"Monteforte","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2006.10.014","article-title":"Cryptococcal meningitis in a patient treated with infliximab","volume":"57","author":"Mu\u00f1oz","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib34","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib35","first-page":"549","article-title":"Var\u00f3n de 60 a\u00f1os con una cirrosis hep\u00e1tica de 33 a\u00f1os de evoluci\u00f3n, afectado de un proceso respiratorio agudo y una focalidad neurol\u00f3gica","volume":"113","author":"Pedro-Botet Montoya","year":"1999","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.riam.2009.01.001_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00041327-200406000-00008","article-title":"Concurrent sino-orbital aspergillosis and cerebral nocardiosis","volume":"24","author":"Pieroth","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.riam.2009.01.001_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/505430","article-title":"Tumor-necrosis-factor blockers: Differential effects on mycobacterial immunity","volume":"194","author":"Saliu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00002018-200629080-00004","article-title":"Safety of etanercept in psoriasis: A critical review","volume":"29","author":"S\u00e1nchez Carazo","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.riam.2009.01.001_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rdc.2005.10.004","article-title":"New therapeutics in rheumatoid arthritis","volume":"32","author":"Savage","year":"2006","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.riam.2009.01.001_bib40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1503\/cmaj.1040563","article-title":"Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone","volume":"171","author":"Singh","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.riam.2009.01.001_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1183\/09031936.05.00005205","article-title":"Cough and fever in a female with Crohn's disease receiving infliximab","volume":"26","author":"Stratakos","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.riam.2009.01.001_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor \u03b1 blockade therapy","volume":"83","author":"Tsiodras","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.riam.2009.01.001_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10096-004-1263-9","article-title":"Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication","volume":"24","author":"Van Dam","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib44","first-page":"237","article-title":"Invasive pulmonary aspergillosis and nocardiosis in an immunocompromised host","volume":"41","author":"Varma","year":"1993","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.riam.2009.01.001_bib45","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","article-title":"Granulomatous infections due to tumor necrosis factor blockade: Correction","volume":"39","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib46","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1086\/429996","article-title":"Reactivation of latent granulomatous infections by infliximab","volume":"41","author":"Wallis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib47","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious disease associated with tumor necrosis factor antagonist","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.riam.2009.01.001_bib48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.riam.2009.01.001_bib49","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200206-563OC","article-title":"Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy","volume":"167","author":"Wood","year":"2003","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140609000096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140609000096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T04:26:14Z","timestamp":1685075174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140609000096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1130140609000096"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2009.01.001","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}